Inovio Pharmaceuticals, Inc.
Vaccines For Human Papilloma Virus And Methods For Using The Same

Last updated:

Abstract:

Improved anti-HPV immunogens and nucleic acid molecules that encode them are disclosed. Immunogens disclosed include those having consensus HPV39 E6E7 and HPV45 E6E7. Pharmaceutical composition, recombinant vaccines comprising DNA plasmid and live attenuated vaccines are disclosed as well methods of inducing an immune response in an individual against HPV are disclosed.

Status:
Application
Type:

Utility

Filling date:

5 Jan 2021

Issue date:

29 Apr 2021